mechanism of action of glp 1 agonist Frontiers GLP-1 & GIP Agonists |
Description
A pilot study investigating gut microbiomes of 52 patients receiving either Dulaglutide or Liraglutide determined a microbial signature of GLP-1RA responders ( n = 34) and non-responders ( n = 18) (Tsai et al., 2022)
Prebiotic & Probiotic Blend 10 Billion CFU: Formulated with a gut-friendly prebiotic and probiotic blend providing 10 billion CFU (1.010 per serving)
Persistent Results: The drug has shown the potential for continuing weight loss beyond 52 weeks without a clear plateau
Some clinicians manage discontinuation by gradually tapering the dose rather than stopping abruptly, and others transition patients to phentermine or other medications to blunt the regain
Regarding type of surgery, 96% ( n = 96) had undergone sleeve gastrectomy and 4% ( n = 4) distal Roux-en-Y gastric bypass
We have five pharmacists and a complement of technician analysts with over 50 years of dedicated audit assistance experience
